Cite
HARVARD Citation
Brown, G. et al. (2017). The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited. International journal of retina and vitreous. 3 (1), pp. 1-11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brown, G. et al. (2017). The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited. International journal of retina and vitreous. 3 (1), pp. 1-11. [Online].